 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 02/19/2021 |
$7.27 |
$7.64 |
$7.24 |
$7.50 |
425.10K | | 02/22/2021 |
$7.57 |
$7.71 |
$6.81 |
$6.83 |
614.40K | | 02/23/2021 |
$6.67 |
$6.67 |
$6.05 |
$6.24 |
809.00K | | 02/24/2021 |
$6.25 |
$7.05 |
$6.25 |
$6.65 |
617.70K | | 02/25/2021 |
$6.65 |
$6.80 |
$5.70 |
$6.14 |
511.80K |
|
|
| Capricor Therapeutics is a clinical-stage biotechnology company focused on the discovery, development and commercialization of biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy (DMD), and other rare disorders. Co. is conducting HOPE-2, a Phase II clinical trial in the United States with its product candidate, CAP-1002, a cardiac cell derived therapy which is being used to treat patients with late-stage DMD. Additionally, Co. is developing its exosomes platform technology as a vaccine and therapeutic investigating a variety of disorders. Exosomes act as messengers to regulate the functions of neighboring or distant cells. | |
|
Capricor Therapeutics (CAPR) has the following price history information. Looking back at CAPR historical stock prices for the last five trading days, on February 19, 2021, CAPR opened at $7.27, traded as high as $7.64 and as low as $7.24, and closed at $7.50. Trading volume was a total of 425.10K shares. On February 22, 2021, CAPR opened at $7.57, traded as high as $7.71 and as low as $6.81, and closed at $6.83. Trading volume was a total of 614.40K shares. On February 23, 2021, CAPR opened at $6.67, traded as high as $6.67 and as low as $6.05, and closed at $6.24. Trading volume was a total of 809.00K shares. On February 24, 2021, CAPR opened at $6.25, traded as high as $7.05 and as low as $6.25, and closed at $6.65. Trading volume was a total of 617.70K shares. On February 25, 2021, CAPR opened at $6.65, traded as high as $6.80 and as low as $5.70, and closed at $6.14. Trading volume was a total of 511.80K shares.
CAPR Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Capricor Therapeutics shares, starting with a $10,000 purchase of CAPR, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
02/28/2011 |
|
| End date: |
02/25/2021 |
|
| Start price/share: |
$6.00 |
|
| End price/share: |
$6.14 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
2.33% |
|
| Average Annual Total Return: |
0.23% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$10,232.40 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 02/19/2021 | $7.50 | | 02/22/2021 | $6.83 | | 02/23/2021 | $6.24 | | 02/24/2021 | $6.65 | | 02/25/2021 | $6.14 |
|
|
